Division of Cancer Control, Research Institute for National Cancer Control and Evaluation, National Cancer Center, Goyang, Gyeonggi, Korea.
BMC Health Serv Res. 2010 Feb 23;10:48. doi: 10.1186/1472-6963-10-48.
Although some studies examined the association between shared decision-making (SDM) and type of breast cancer surgery received, it is little known how treatment decisions might be shaped by the information provided by physicians. The purpose of this study was to identify the associations between shared decision making (SDM) and surgical treatment received.
Questionnaires on SDM were administered to 1,893 women undergoing primary curative surgery for newly diagnosed stage 0-II localized breast cancer at five hospitals in Korea. Questions included being informed on treatment options and the patient's own opinion in decision-making.
Patients more likely to undergo mastectomy were those whose opinions were respected in treatment decisions (adjusted odds ratio, aOR), 1.40; 95% confidence interval (CI), 1.14-1.72) and who were informed on chemotherapy (aOR, 2.57; CI, 2.20-3.01) or hormone therapy (aOR, 2.03; CI, 1.77-2.32). In contrast, patients less likely to undergo mastectomy were those who were more informed on breast surgery options (aOR, 0.34; CI, 0.27-0.42). In patients diagnosed with stage 0-IIa cancer, clinical factors and the provision of information on treatment by the doctor were associated with treatment decisions. In patients diagnosed with stage IIb cancer, the patient's opinion was more respected in treatment decisions.
Our population-based study suggested that women's treatment decisions might be shaped by the information provided by physicians, and that women might request different information from their physicians based on their preferred treatment options. These results might need to be confirmed in other studies of treatment decisions.
尽管一些研究考察了共享决策(SDM)与接受的乳腺癌手术类型之间的关系,但对于医生提供的信息如何影响治疗决策知之甚少。本研究旨在确定共享决策(SDM)与接受的手术治疗之间的关联。
在韩国的五家医院,对 1893 名接受新诊断的 0-II 期局部乳腺癌原发性治愈性手术的女性进行了 SDM 问卷。问题包括治疗方案的告知和患者在决策中的意见。
在接受手术治疗的患者中,那些在治疗决策中尊重其意见的患者(调整后的优势比,aOR)更有可能接受乳房切除术,aOR 为 1.40;95%置信区间(CI)为 1.14-1.72)和接受化疗(aOR,2.57;CI,2.20-3.01)或激素治疗(aOR,2.03;CI,1.77-2.32)的患者。相反,那些对乳房手术选择了解更多的患者不太可能接受乳房切除术(aOR,0.34;CI,0.27-0.42)。在诊断为 0-IIa 期癌症的患者中,临床因素和医生提供的治疗信息与治疗决策相关。在诊断为 IIb 期癌症的患者中,治疗决策中更尊重患者的意见。
本基于人群的研究表明,女性的治疗决策可能受到医生提供的信息的影响,并且女性可能根据其首选的治疗方案向医生请求不同的信息。这些结果可能需要在其他治疗决策研究中得到证实。